Recombinant hydrolases as anti-biofilm therapies for Aspergillus infections

重组水解酶作为曲霉菌感染的抗生物膜疗法

• 批准号: 325289
• 负责人: Sheppard Donald C
• 金额: $ 11.03万
• 依托单位: Research Institute of the McGill University Health Centre
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-02-01 至 2016-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=325289&lang=en
• 关键词: Antifungals; Biofilm; Enzyme Therapy; Fungal Disease; Respiratory Disease

Lung infections are one of the most important causes of death in patients whose immune systems do not work properly because of chemotherapy, organ and bone marrow transplantation or the use of immune suppressing medications like steroids. These infections

肺部感染是因化疗、器官和骨髓移植或使用类固醇等免疫抑制药物而导致免疫系统无法正常工作的患者最重要的死亡原因之一。这些感染